Abstract
A prospective randomised, double blind, controlled trial was conducted in 52 infants to determine whether recombinant interferon alfa-2a (INF-alpha-2a) would reduce the morbidity of acute bronchiolitis and the respiratory syncytial virus shedding time. All infants had a positive direct antigen immunofluorescence test for respiratory syncytial virus. INF-alpha-2a (50,000 IU/kg/day) or placebo was administered by daily intramuscular injection for three consecutive days. Sixteen infants received INF-alpha-2a and 36 received placebo treatment. The two groups were similar in demographic characteristics and initial oxygenation. The treatment group, however, had a significantly higher overall score for severity of illness at the start of treatment. More rapid drop of the clinical score was observed in the INF-alpha-2a group after treatment in the first three days and the two groups had similar clinical severity by day 3. There was no significant difference of the duration of viral shedding in the two groups. In conclusion, the overall clinical improvement was greater in the treatment group over the first three days, but the duration of viral shedding was not altered.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gardner P. S., McGuckin R., Beale A., Fernandes R. Interferon and respiratory syncytial virus. Lancet. 1970 Mar 14;1(7646):574–575. doi: 10.1016/s0140-6736(70)90821-4. [DOI] [PubMed] [Google Scholar]
- Hall C. B., Douglas R. G., Jr, Simons R. L., Geiman J. M. Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr. 1978 Jul;93(1):28–32. doi: 10.1016/s0022-3476(78)80594-0. [DOI] [PubMed] [Google Scholar]
- Isaacs D. Production of interferon in respiratory syncytial virus bronchiolitis. Arch Dis Child. 1989 Jan;64(1):92–95. doi: 10.1136/adc.64.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969 Apr;89(4):422–434. doi: 10.1093/oxfordjournals.aje.a120955. [DOI] [PubMed] [Google Scholar]
- Lauer B. A., Masters H. A., Wren C. G., Levin M. J. Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay. J Clin Microbiol. 1985 Nov;22(5):782–785. doi: 10.1128/jcm.22.5.782-785.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moehring J. M., Forsyth B. R. The role of the interferon system in respiratory syncytial virus infections. Proc Soc Exp Biol Med. 1971 Dec;138(3):1009–1014. doi: 10.3181/00379727-138-36039. [DOI] [PubMed] [Google Scholar]
- Portnoy J., Hicks R., Pacheco F., Olson L. Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus. Antimicrob Agents Chemother. 1988 Apr;32(4):589–591. doi: 10.1128/aac.32.4.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sung R. Y., Chan R. C., Tam J. S., Cheng A. F., Murray H. G. Epidemiology and aetiology of acute bronchiolitis in Hong Kong infants. Epidemiol Infect. 1992 Feb;108(1):147–154. doi: 10.1017/s0950268800049591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sung R. Y., Murray H. G., Chan R. C., Davies D. P., French G. L. Seasonal patterns of respiratory syncytial virus infection in Hong Kong: a preliminary report. J Infect Dis. 1987 Sep;156(3):527–528. doi: 10.1093/infdis/156.3.527. [DOI] [PubMed] [Google Scholar]
- Taylor C. E., Webb M. S., Milner A. D., Milner P. D., Morgan L. A., Scott R., Stokes G. M., Swarbrick A. S., Toms G. L. Interferon alfa, infectious virus, and virus antigen secretion in respiratory syncytial virus infections of graded severity. Arch Dis Child. 1989 Dec;64(12):1656–1660. doi: 10.1136/adc.64.12.1656. [DOI] [PMC free article] [PubMed] [Google Scholar]